Zynex P/FCF
Quel est le P/FCF de Zynex?
Le P/FCF de Zynex, Inc. est 33.36
Quelle est la définition de P/FCF?
Le rapport prix / flux de trésorerie disponibles (P / FCF) est une mesure d'évaluation qui compare le prix actuel de l'action de la société à son flux de trésorerie disponible par action.
Price to free cash flow (P/FCF) is a measure that value investors find useful to analyze a company’s finances in relation to its current stock price. It is a stricter measure than the price to cash flow ratio as it subtracts capital expenditures from cash flow.
Free cash flow relies heavily on the state of a company's cash from operations, which is in turn heavily influenced by the company's net income. Companies can manipulate their free cash flow by lengthening the time they take to pay their bills, shortening the time it takes to collect what's owed to them, and putting off buying inventory. It also depends on what items are considered capital expenditures and this can be different in case of different companies.
Lower values of P/FCF generally indicate a company that is undervalued and whose stock is relatively cheap in relation to its free cash flow. Conversely, higher P/FCF indicate that the company's stock is relatively overvalued. Value investors thus favor companies with low or decreasing price to free cash flow values that indicate high or increasing free cash flow totals and relatively low stock share prices.
It is best to compare price to free cash flow ratios between similar companies in the same industry. However, the P/FCF metric can also be viewed over a longer time frame to see if the company's cash flow to share price value is improving or declining.
P/FCF des entreprises dans Health Care secteur sur SZSE par rapport à Zynex
Que fait Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Entreprises avec p/fcf similaire à Zynex
- Dollar General a P/FCF de 33.27
- Flir Systems a P/FCF de 33.30
- Shoals Technologies a P/FCF de 33.30
- Dadi International a P/FCF de 33.30
- Guangdong Adway Construction () a P/FCF de 33.31
- Lemaitre Vascular Inc a P/FCF de 33.32
- Zynex a P/FCF de 33.36
- Dewhurst plc a P/FCF de 33.37
- Mack-Cali Realty a P/FCF de 33.37
- Pacific Mercantile Bancorp a P/FCF de 33.37
- Matador Resources Co a P/FCF de 33.38
- Mirvac Stapled Securities a P/FCF de 33.39
- Atrium European Real Estate a P/FCF de 33.40